| Priority actions for the non-communicable disease crisis R Beaglehole, R Bonita, R Horton, C Adams, G Alleyne, P Asaria, ... The lancet 377 (9775), 1438-1447, 2011 | 2252 | 2011 |
| Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries R Moodie, D Stuckler, C Monteiro, N Sheron, B Neal, T Thamarangsi, ... The lancet 381 (9867), 670-679, 2013 | 1901 | 2013 |
| Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies L Pimpin, H Cortez-Pinto, F Negro, E Corbould, JV Lazarus, L Webber, ... Journal of hepatology 69 (3), 718-735, 2018 | 750 | 2018 |
| Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol … R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ... The Lancet 384 (9958), 1953-1997, 2014 | 680 | 2014 |
| Increased plasma tumor necrosis factor in severe alcoholic hepatitis GLA Bird, N Sheron, AKJ Goka, GJ Alexander, RS Williams Annals of internal medicine 112 (12), 917-920, 1990 | 580 | 1990 |
| Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease C Banks, A Bateman, R Payne, P Johnson, N Sheron The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 421 | 2003 |
| Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and Fibrosis K Thompson, J Maltby, J Fallowfield, M McAulay, H Millward-Sadler, ... Hepatology 28 (6), 1597-1606, 1998 | 367 | 1998 |
| A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective R Burton, C Henn, D Lavoie, R O'Connor, C Perkins, K Sweeney, ... The Lancet 389 (10078), 1558-1580, 2017 | 363 | 2017 |
| Hepatic changes in the failing Fontan circulation CH Kiesewetter, N Sheron, JJ Vettukattill, N Hacking, B Stedman, ... Heart 93 (5), 579-584, 2007 | 358 | 2007 |
| Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study E Scorletti, L Bhatia, KG McCormick, GF Clough, K Nash, L Hodson, ... Hepatology 60 (4), 1211-1221, 2014 | 347 | 2014 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 334 | 2022 |
| No level of alcohol consumption improves health R Burton, N Sheron The Lancet 392 (10152), 987-988, 2018 | 298 | 2018 |
| Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration N Sheron, G Bird, J Koskinas, B Portmann, M Ceska, I Lindley, R William Hepatology 18 (1), 41-46, 1993 | 276 | 1993 |
| The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals MA Bellis, K Hughes, J Nicholls, N Sheron, I Gilmore, L Jones BMC public health 16, 1-10, 2016 | 271 | 2016 |
| Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK R Williams, G Alexander, I Armstrong, A Baker, N Bhala, G Camps-Walsh, ... The Lancet 391 (10125), 1097-1107, 2018 | 174 | 2018 |
| Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. N Sheron, G Bird, J Goka, G Alexander, R Williams Clinical and experimental immunology 84 (3), 449, 1991 | 169 | 1991 |
| Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection N Sheron, J Lau, H Daniels, J Goka, A Eddleston, GJM Alexander, ... Journal of hepatology 12 (2), 241-245, 1991 | 167 | 1991 |
| Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis J Maltby, S Wright, G Bird, N Sheron Hepatology 24 (5), 1156-1160, 1996 | 159 | 1996 |
| Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study TJ Kendall, B Stedman, N Hacking, M Haw, JJ Vettukattill, AP Salmon, ... Journal of clinical pathology 61 (4), 504-508, 2008 | 155 | 2008 |
| Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin‐10 during the course of activation in vitro KC Thompson, A Trowern, A Fowell, M Marathe, C Haycock, MJ Arthur, ... Hepatology 28 (6), 1518-1524, 1998 | 152 | 1998 |
